Penile cancer: Epidemiology and treatment

Current Oncology Reports

Volumn 13, Issue 3, 2011, Pages 231-239

  Guimarães, Gustavo Cardoso ^a   Rocha, Rafael Malagoli ^a   Zequi, Stenio Cassio ^a   Cunha, Isabela Werneck ^a   Soares, Fernando Augusto ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Epidemiology; Penile cancer; Prognostic factors; Treatment

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; CELL ADHESION MOLECULE; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; IFOSFAMIDE; IRINOTECAN; MATRIX METALLOPROTEINASE; METHOTREXATE; PACLITAXEL; PROTEIN P53;

ARTICLE; BALANITIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LICHEN; LICHEN SCLEROSUS ET ATROPHICUS; LOW LEVEL LASER THERAPY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PENIS AMPUTATION; PENIS CANCER; PERSONAL HYGIENE; PHIMOSIS; PROGNOSIS; SMOKING; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PENILE NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955897020     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-011-0163-2     Document Type: Article

References (62)

1. Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007;25:361-7. (Pubitemid 47362755)
2. Dai B, Ye DW, Kong YY, Yao XD, Zhang HL, Shen YJ. Predicting regional lymph node metastasis in Chinese patients with penile squamous cell carcinoma: the role of histopathologic classification, tumor stage and depth of invasion. J Urol. 2006;176:1431-5. (Pubitemid 44307211)
3. Ritchie AW, Foster PW, Fowler S. Penile cancer in the UK. Clinical presentation and outcome in 1998/99. BJU Int. 2004;94:1248-52.
4. Kamat MR, Kulkarni JN, Tongonkar HB. Carcinoma of the penis: the Indian experience. J Surg Oncol. 1993;52:50-5. (Pubitemid 23032110)
5. Persky L. Epidemiology of cancer of the penis. Rec Results Cancer Res. 1997;60:97-109.
6. Velazquez EF, Cubilla AF. Penile squamous cell carcinoma. Anatomic, Pathologic and viral studies in Paraguay (1993-2007). Anal Quant Cytol Histol. 2007;29:185-98.
7. Favorito LA, Nardi AC, Ronalsa M, Zequi SC, Sampaio FJ, Glina S. Epidemiologic study on penile cancer in Brazil. Int Braz J Urol. 2008;34(5):587-91.
8. Goolamali SI, Pakianathan M. Penile carcinoma arising in balanitis xerotica obliterans. Int J STD AIDS. 2006;17:135-6.
9. Cubilla AL, Velazquez EF, Young RH. Pseudohyperplastic squamous cell carcinoma of the penis associated with lichen sclerosus. An extremely well-differentiated, nonverruciform neoplasm that preferentially affects foreskin and is frequently misdiagnosed. Am J Surg Pathol. 2004;28:895-900. (Pubitemid 38856845)
10. Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis. Am J Surg Pathol. 2003;27:1448-53.
11. Frew IDO, Jefferies JD, Swinney J. Carcinoma of the penis. Br J Urol. 1976;39:398-404.
12. Frisch M, Friis S, Kjaer SK. MELBYE KM. Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90). BMJ. 1995;311:1471.
13. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001.
14. Bezerra ALR, Lopes A, Santiago GH, Ribeiro KCB, Latorre MRDO, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis. Analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91:2315-21.
15. Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer. 2008;123:1832-40.
16. Schneider MA, Campos MM, Ornellas AA, Chin EW, Ornellas MH, Andrada-serpa MJ. Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features. Int Braz J Urol. 2008;34:467-76.
17. Cubilla AL, Velazquez EF, Reuter VE, Oliva E, Mihm MC, Young RH. Warty (condylomatous) squamous cell carcinoma of the penis. A report of 11 cases and proposed classification of "verruciform" penile tumors. Am J Surg Pathol. 2000;24:505-12.
18. Lont AP, Kroon BK, Horenblas S, Gallee MP, Berkhof J, Meijer CJ, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts avorable outcome in survival. Int J Cancer. 2006;119(5):1078-81. (Pubitemid 44116916)
19. Zequi SC, Guimaraes GC, Fonseca FP, et al. Sex with animals (SWA): characteristics and possible associations with penile cancer and sexually transmitted disease. actual results. A multicentric Brazilian case-control study. J Urol. 2010;183(4, Supplement): e8.
20. Johnson DE, Fuerst DE, Ayala AG. Carcinoma of the penis: experience in 153 cases. Urology. 1973;1:404-8.
21. Solsona E, Iborra I, Rubio J, Casanova JL, Ricós JV, Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol. 2001;165:1506-9. (Pubitemid 32410225)
22. Novara G, Galfano A, de Marco V, Artibani W, Ficarra V. Prognostic factors in squamous cell carcinoma of the penis. Nat Clin Pract. 2007;4:140-6. (Pubitemid 46416278)
23. Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992;19(2):247-56.
24. Muneer A, Kayes O, Ahmed HU, Arya M, Minhas S. Molecular prognostic factors in penile cancer. World J Urol. 2009;27(2):161-7. This is an important paper with an extensive review of molecular prognostic factors in penile cancer.
25. Cubilla AL, Ayala G, Dillner J, Reuter V, Schellhammer PF, von Krogh G, et al. Malignat epithelial tumors of the penis. In: Eble JN, Sauter G, Epstein JI, Sesterhann IA, editors. World Health Organization classification of the tumors. Pathology and genetics. Tumors of the urinary system and male genital organs. Lyon: IARC; 2004. p. 281-90.
26. Guimarães GC, Cunha IW, Soares FA, Lopes A, Torres JJ, Chaux A, et al. WHO histological classification, regional metastasis and outcome in 372 surgically treated patients with penile squamous cell carcinoma. Lab Invest. 2007;87:150A.
27. Guimarães GC, Cunha IW, Soares FA, Lopes A, Torres J, Chaux A, et al. Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol. 2009;182(2):528-34. This manuscript reviews the pathological classification of penile cancer and its clinical correlation.
28. Cubilla AL. The role of pathologic prognostic factors in squamous cell carcinoma of the penis. World J Urol. 2009;27(2):169-77.
29. Cunha IW, Guimaraes GC, Soares F, Velazquez E, Torres JJ, Chaux A, et al. Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol. 2009;33(4):551-5.
30. Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;1156:1637-42. (Pubitemid 26344009)
31. Biedrzycki OJ, Hadway P, Cooke A, Watkin N, Corbishley C. Immunohistochemical analysis of negative inguinal lymph node in men with squamous cell carcinoma: are we missing micrometastases which could predict recurrence. BJU Int. 2006;98:70-3. (Pubitemid 43885508)
32. Velazquez EF, Ayala G, Liu Hm, Chaux A, Zanotti M, Tores J, et al. Histologic grade and perineural invasion is more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008;32:974-9. This manuscript is the first to present perineural invasion as an independent risk factor for lymph node metastasis.
33. Leitje JAP, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54:161-9.
34. Cubilla AL, Piris A, Pfanni R, Rodriguez I, Aguero F, Young RH. Anatomic levels: important landmarks in penectomy specimens: a detailed anatomic and histologic study based on examination of 44 cases. Am J Surg Pathol. 2001;25:1091-4. (Pubitemid 32685909)
35. Guimarães GC, Lopes A, Campos RSM, Zequi SC, Leal MLO, Carvalho AL, et al. Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastasis. Urology. 2006;68:148-53. (Pubitemid 44037722)
36. Velazquez EF, Soskin A, Bock A, Codas R, Barreto JE, Cubilla AL. Positive resection margins in partial penectomies: sites of involvement and proposal of local routes of spread of penile squamous cell carcinoma. Am J Surg Pathol. 2004;28(3):384-9. (Pubitemid 38269573)
37. Cubilla AL, Ayala G, Lopes A, Guimarães GC, Oliveira ML, Torres JJ, et al. Perineural invasion (PNI) predicts mortality in penile squamous cell carcinoma. A long-term outcome study comparing clinico-pathologic features. Lab Invest. 2007;87:142A.
38. Berdjis N, Meye A, Nippgen J, Dittert D, Hakenberg O, Baretton GB, et al. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int. 2005;96:146-8. (Pubitemid 40942886)
39. Berney DM, Stankiewicz E, Adlan AMA, Kudahetti S, Biedrzycki OJ, Hadway P, et al. DNA topoisomerase I and IIα expression in penile carcinomas: assessing potential tumor chemosensitivity. BJU Int. 2008;102:1040-4.
40. Martins ACP, Faria SM, Cologna AJ, Suaid HJ, Tucci Jr S. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol. 2002;167:89-93.
41. Guimarães GC, Leal MLO, Campos RSM, Zequi SC, Fonseca FP, Cunha IW, et al. Do proliferating cell nuclear antigen and MIB-1/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology. 2007;70:137-42.
42. Lopes A, Bezerra ALR, Pinto CAL, Serrano SV, Mello CA, Villa LL. P53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol. 2002;168:81-6. (Pubitemid 34640788)
43. TorneseloML, Duraturo ML, Guida V, Losito S, Botti G, Pilotti S, et al. Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma. Cancer Lett. 2008;269:159-64.
44. Campos RSM, Lopes A, Guimarães GC, Carvalho AL, Soares FA. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology. 2006;67:797-802.
45. Greenbaum SS, Glogan R, Stegman SJ, Tromovich TA. Carbon dioxide laser treatment of erythroplasia of Queyrat. J Urol. 1999;161:893-4.
46. Bandieramonte G, Colecchia M, Mariani L, et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol. 2008;54(4):875-82.
47. Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am. 1992;19:291-304.
48. Duncan W, Jackson SM. The treatment of early cancer of the penis with megavoltage x-rays. Clin Radiol. 1972;23:246-8.
49. Greenberg RE.Surgical management of carcinoma of the penis. Urol Clin North Am. 2010; 37(3):369-78. In this paper, the author makes a critical analysis on the surgical aspects of the treatment options for the primary tumor, with good illustrations.
50. Pettaway CA, Pagliaro L, Theodore C, Haas G. Treatment of visceral,unresectable, or bulky/unresectable regional metastases of penile cancer.Urology. 2010;76(2 Suppl 1):S58-65. Important manuscript on advanced disease and treatment options.
51. Derrick Jr FC, Lynch KM, Kretkowski RC, Yarbrough W. Epidermoid carcinoma of the penis: computer analysis of 87 cases. J Urol. 1973;110:303-5.
52. Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H. Management of the lymph nodes in penile cancer. Urology. 2010;76(2 Suppl 1):S43-57. This is a comprehensive literature study evaluating the levels of evidence in publications about the treatment of lymph nodes in penile cancer patients.
53. Lopes A, Rossi BM, Fonseca FO, Morini S. Unrealiability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer. 1996;77:2099-102. (Pubitemid 26142055)
54. Protzel C, Alcaraz A, Horenblas S, Pizzocaro G, Zlotta A, Hakenberg OW. Lymphadenectomy in the surgical management of penile cancer. Eur Urol. 2009;55(5):1075-88.
55. Coblentz TR, Theodorescu D. Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis. J Urol. 2002;168:1386-9. (Pubitemid 35034128)
56. Lopes A, Bezerra AL, Serrano SV, Hidalgo GS. Iliac nodal metástases from carcinoma of the penis treated surgically: analysis of 13 cases. Br J Urol. 2000;86:690-3.
57. Gagliano RG, Blumenstein BA, Crawford ED, et al. Cisdiamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1989;141:66-7. (Pubitemid 19028828)
58. Ahmed T, Sklaroff R, Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol. 1984;132:465-8. (Pubitemid 14026145)
59. Haas GP, Blumenstein BA, Gagliano RG, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1999;161:1823-5. (Pubitemid 29420741)
60. Pagliaro LC, Williams DL, Daliani D, et al. Neoadjuvant paclitaxel (P), ifosfamide (I), and cisplatin (C) chemotherapy prior to inguinal/pelvic lymphadenectomy for stage Tany, N2-3, M0 squamous carcinoma (SCC) of the penis. J Urol. 2006;175 (suppl):195.
61. Theodore C, Skoneczna I, Bodrogi I, et al. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC protocol 30992). Ann Oncol. 2008;19:1304-7. (Pubitemid 351911962)
62. Heidenreich A, Thüer D, Pfister D. Value of targeted therapy for penile cacer. Urologe A. 2008;47(10):1320-7.